Justin Ahdan

Decommissioned: The Serialisation Podcast

Science EN ↓ 3 epizód

Decommissioned: The Serialisation Podcast is your monthly guide to global pharma serialisation and track-and-trace compliance. From the EU FMD and US DSCSA to emerging regulations worldwide, we debate key topics, real-world implementations, and gather expert insights. Tune in each month for practical perspectives from MAHs, CMOs, tech providers, and regulators. Subscribe to for an unadulterated perspective on a serialisation landscape.

Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: sites.libsyn.com

Szerző

Justin Ahdan

Kategória

Science

A podcast weboldala

sites.libsyn.com

Legutóbbi epizód

2026. ápr. 13.

Hol hallgathatod?

Podcastok az alkalmazásban Replaio Radio Hamarosan

A podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz

Telepítsd ingyen Android közel 10 M letöltés · 4,8-as értékelés iOS hamarosan

Epizódok

Artificial Intelligence 13.04.2026 1:12:21

Is AI the next leap forward for pharmaceutical serialization, or the latest buzzword wrapped in sales promises? In this episode of Decommission, hosts Scott Pugh, Jerome Burton, and Justin Ahdan are joined by three technology providers in serialization: Dimitar Iliev, Director of Software Development at SoftGroup; Abiram Vijayakumar co-founder of AltiusHub; and John Winkler, CTO at Trust.med. Toge...

Standard Deviation - When Data Standards Deliver… or Don’t 26.11.2025 50:25

Data standards are meant to simplify serialization operations — not complicate them. In this episode of Decommissioned, Jerome Bertin, Scott Pugh, and Justin Ahdan explore where the pharmaceutical industry’s data standards truly help — and where misapplication, proprietary detours, and weak enforcement create noise, cost, and confusion. From the US DSCSA to the EU FMD, the trio break down how adhe...

Between the Scans 08.08.2025 49:11

With DSCSA enforcement looming, this episode dives into the global fight against counterfeit medicines. Scott and Jerome compare the U.S.'s decentralized approach with the EU's centralized FMD system, highlighting key milestones, rollout challenges, and what's at stake. From tech alignment to pharmacy realities and SME struggles, get insights on what's worked, what hasn't, and what's next for phar...